Management of acute, lower extremity surgical wounds using an ablative fractional laser: A single-center, randomized, double-blinded controlled trial

Abstract

To the Editor: It has been estimated that 5.4 million new cases of nonmelanoma skin cancer are diagnosed each year,1 with up to 10% of basal cell carcinomas and 20% of squamous cell carcinomas occurring on the lower extremities.2 The treatment for nonmelanoma skin cancer is often destructive or surgical, with Mohs micrographic surgery frequently used for skin cancers below the knee. This increase in the incidence of skin cancer on the lower extremities results in an increase in the number of postoperative lower extremity wounds.